Ziopharm Oncology to Report Second Quarter Financial Results on August 9, 2021

NEXT STORY
Brown & Brown, Inc. Announces Quarterly Revenues of $727.3 Million, an Increase of 21.5%, and Diluted Net Income Per Share of $0.49
PREV STORY
Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Entasis Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update

Completed $75.0 million initial public offering in September Reported positive Phase 2 topline results ...

author_avatar
NASDAQ Market News

Eftilagimod Alpha (LAG-3Ig Or IMP321) Pre-IND Meeting With the FDA

SYDNEY, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) ...

author_avatar
NASDAQ Market News

Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences

PLYMOUTH MEETING, Pa., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) ...

author_avatar
NASDAQ Market News